Cozaar and Ibrutinib drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cozaar (losartan potassium) and Ibrutinib (ibrutinib). Common drug interactions include abdominal pain among females and bradycardia among males.

The phase IV clinical study analyzes what interactions people have when they take Cozaar and Ibrutinib. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Cozaar?

Cozaar has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 45,124 Cozaar users. Check the latest studies of Cozaar.

What is Ibrutinib?

Ibrutinib has active ingredients of ibrutinib. eHealthMe is studying from 13,529 Ibrutinib users. Check the latest studies of Ibrutinib.



On Jul, 06, 2026

26 people who take Cozaar and Ibrutinib together, and have interactions are studied.

Cozaar and Ibrutinib drug interactions.

What are the common drug interactions of Cozaar and Ibrutinib, by gender? *:

female:

  1. Abdominal pain
  2. Haematuria (presence of blood in urine)
  3. Subcutaneous haematoma (collection of blood outside the blood vessels on the skin)
  4. Face oedema (swelling of face)
  5. Oedema peripheral (superficial swelling)
  6. Fatigue (feeling of tiredness)
  7. Obstructive uropathy (a blockage that prevents urine from leaving your kidneys)
  8. Pancreatic carcinoma (pancreatic cancer)
  9. Presyncope
  10. Arthralgia (joint pain)

male:

  1. Bradycardia (abnormally slow heart action)
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Duodenitis (inflammation of the duodenum)
  4. Anuria (failure of the kidneys to produce urine)
  5. Asthenia (weakness)
  6. Cardiac failure
  7. Cardiogenic shock (inadequate circulation of blood)
  8. Hepatitis acute
  9. Hepatocellular injury (liver injury)
  10. Hypercapnia (too much smoke)

What are the common drug interactions of Cozaar and Ibrutinib, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Bladder transitional cell carcinoma (types of bladder cancer)

60+:

  1. Abdominal pain
  2. Haematuria (presence of blood in urine)
  3. Pancreatic carcinoma (pancreatic cancer)
  4. Presyncope
  5. Sinusitis (inflammation of sinus)
  6. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
  7. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  8. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  9. Arthralgia (joint pain)
  10. Contusion (a type of hematoma of tissue in which capillaries)

What are the existing conditions these people have? *

  1. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 10 people, 38.46%
  2. Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 8 people, 30.77%
  3. Nausea (feeling of having an urge to vomit): 7 people, 26.92%
  4. Stress And Anxiety: 7 people, 26.92%
  5. Nausea And Vomiting: 6 people, 23.08%
  6. Sleep Disorder: 5 people, 19.23%
  7. Pain: 5 people, 19.23%
  8. Hypersensitivity: 4 people, 15.38%
  9. Depression: 4 people, 15.38%
  10. Pancreatic Carcinoma Metastatic (pancreatic cancer- metastatic): 3 people, 11.54%

* Approximation only. Some reports may have incomplete information.

Do you take Cozaar and Ibrutinib?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cozaar and Ibrutinib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cozaar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ibrutinib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cozaar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ibrutinib and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on losartan potassium and ibrutinib (the active ingredients of Cozaar and Ibrutinib, respectively), and Cozaar and Ibrutinib (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: